Grantham, Mayo, Van Otterloo & Co (GMO)’s Barclays BCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$262K Sell
9,746
-11,000
-53% -$265K ﹤0.01% 617
2026
Q1
$439K Sell
20,746
-4,300
-17% -$105K ﹤0.01% 560
2025
Q4
$637K Sell
25,046
-21,872
-47% -$485K ﹤0.01% 558
2025
Q3
$970K Sell
46,918
-4,587
-9% -$90.8K ﹤0.01% 488
2025
Q2
$957K Sell
51,505
-433,606
-89% -$7.17M ﹤0.01% 490
2025
Q1
$7.45M Buy
+485,111
New +$7.26M 0.02% 268
2023
Q4
Sell
-2,121,462
Closed -$16.5M 497
2023
Q3
$16.5M Buy
2,121,462
+1,264,134
+147% +$9.81M 0.08% 204
2023
Q2
$6.74M Buy
857,328
+660,628
+336% +$5.11M 0.03% 301
2023
Q1
$1.41M Buy
+196,700
New +$1.63M 0.01% 453
2022
Q2
Sell
-384,300
Closed -$3.04M 750
2022
Q1
$3.04M Sell
384,300
-394,600
-51% -$4.03M 0.01% 403
2021
Q4
$8.06M Sell
778,900
-72,000
-8% -$755K 0.04% 286
2021
Q3
$8.78M Buy
850,900
+292,000
+52% +$2.91M 0.04% 273
2021
Q2
$5.39M Buy
+558,900
New +$5.71M 0.03% 327

Other funds holding BCS

Grantham, Mayo, Van Otterloo & Co (GMO)'s BCS Position: Q2 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) reduced its Barclays (BCS) stake by 53% in Q2 2026, selling an estimated $265K and leaving 9,746 shares worth $262K. The position accounts for ﹤0.01% of the portfolio, ranked #617.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in BCS in Q2 2021 and has held it in 13 quarters since. The position peaked at $16.5M in Q3 2023. 557 funds tracked by Wall St. Rank hold BCS as of Q2 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 9,746 shares of Barclays worth $262K as of Q2 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 11,000 Barclays shares in Q2 2026, an estimated $265K.
  • Barclays made up ﹤0.01% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q2 2026, its #617 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Barclays in Q2 2021 and has held it in 13 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Barclays position peaked at $16.5M in Q3 2023.
  • 557 funds tracked by Wall St. Rank held Barclays as of Q2 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2026, filed 13 Aug 2026.